GSK (GSK) stock slips as FDA advisors vote against the approval of a combination regimen involving thecompany's blood cancer drug Blenrep. Read more here.

Texas Capital Bancshares posts record Q2 2025 growth with 16% revenue rise, 100% income surge, & robust loan expansion.

Texas Capital Bancshares, Inc. ( NASDAQ: TCBI) Q2 2025 Earnings Conference Call July 17, 2025 9:00 AM ET Jocelyn Kukulka - Corporate Participant John Matthew Scurlock - MD & CFO Robert C. Holmes - ...

Learn why FITB's credit risk has stabilized but challenges in deposits, net interest margin, and valuation make it a cautious ...

Opendoor’s meme-fueled rally is partly backed by subtle macroenvironment relief and a strategic shift. Read why I think OPEN ...

PepsiCo faces weak volume trends, high debt, and growth challenges despite an earnings beat. Read why I see better ...

Fifth Third Bancorp beats Q2 2025 estimates with strong loan growth, raised NII guidance, and resilient balance sheet.

In today’s equity market, mega-cap stocks are not just influential—they have become a driving force shaping overall ...

This monthly article series provides a top-down analysis of the consumer staples sector based on value, quality, and momentum ...

Discover why El Pollo Loco's rating shifts from 'buy' to 'hold' amid declining traffic, slowed sales growth, and rising costs ...

CuriosityStream (CURI) stock pulls back after earnings surge. Insider selling and AI strategy raise concerns, but guidance hints at future growth.

Q2 2025 Earnings Conference Call July 17, 2025 8:30 AM ETCompany ParticipantsAndrew Jamie Gregory - Executive VP ...